DMK
CORV

David M. Knott’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

David M. Knott’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-67,978
Closed -$105K – 118
2017
Q4 		$105K Sell
67,978
-66,500
-49% -$107K 0.04% 90
2017
Q3 		$286K Sell
134,478
-100
-0.1% -$340 0.12% 69
2017
Q2 		$608K Buy
134,578
+58,278
+76% +$211K 0.25% 45
2017
Q1 		$230K Buy
+76,300
New +$225K 0.11% 48

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

David M. Knott's CORV Position: Q1 2018 in Review

David M. Knott sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q1 2018, closing a stake of 67,978 shares — an estimated $105K sold.

David M. Knott first reported a position in CORV in Q1 2017 and held it in 4 quarters. The position peaked at $608K in Q2 2017. 25 funds tracked by Wall St. Rank hold CORV as of Q1 2018.

  • David M. Knott reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q1 2018 after selling out during the quarter.
  • David M. Knott sold 67,978 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q1 2018, an estimated $105K.
  • David M. Knott first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q1 2017 and held it in 4 quarters.
  • David M. Knott's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $608K in Q2 2017.
  • 25 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q1 2018.

Based on David M. Knott's 13F filing for Q1 2018, filed 11 May 2018.